IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans (Q35536380)

8 August 2017

title

IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans (English)

1 reference

8 August 2017

0 references

1 reference

5

1 reference

8 August 2017

Heiner K Berthold

9

0 references

Stefan Rose-John

object named as

Stefan Rose-John

11

0 references

Stefan Schreiber

12

object named as

Stefan Schreiber

1 reference

8 August 2017

Nike Müller

1

1 reference

8 August 2017

Dominik M Schulte

2

1 reference

8 August 2017

Kathrin Türk

3

1 reference

8 August 2017

Sandra Freitag-Wolf

4

1 reference

8 August 2017

Rainald Zeuner

6

1 reference

8 August 2017

Johann O Schröder

7

1 reference

8 August 2017

Ioanna Gouni-Berthold

8

1 reference

8 August 2017

Wilhelm Krone

10

1 reference

8 August 2017

Matthias Laudes

13

1 reference

8 August 2017

language of work or name

1 reference

21 February 2015

1 reference

Journal of Lipid Research

8 August 2017

published in

1 reference

8 August 2017

volume

56

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

1034-1042

1 reference

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Hyperlipoproteinemia(a): clinical significance and treatment options

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

The role of niacin in lipid-lowering treatment: are we aiming too high?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Association between the interleukin-6 promoter polymorphism -174G/C and serum lipoprotein(a) concentrations in humans

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Tristetraprolin mediates anti-inflammatory effects of nicotine in lipopolysaccharide-stimulated macrophages

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Lipoprotein(a): biology and clinical importance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

New developments in the use of niacin for treatment of hyperlipidemia: new considerations in the use of an old drug.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

The mysteries of lipoprotein(a)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Quo vadis haemapheresis. Current developments in haemapheresis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Increased levels of lipoprotein (a) in Crohn's disease: a relation to thrombosis?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4409280

Elevated Lp(a) levels in patients with end-stage renal disease

26 September 2018

1 reference

12 December 2020

Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Protein composition of Lp(a) lipoprotein from human plasma

1 reference

12 December 2020

Transient changes of serum lipoprotein(a) as an acute phase protein

1 reference

12 December 2020

Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis

1 reference

12 December 2020

Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions

1 reference

12 December 2020

Major reduction in plasma Lp(a) levels during sepsis and burns

1 reference

12 December 2020

[Lipoprotein(a) as a risk factor for arteriosclerosis]

1 reference

12 December 2020

Optimal therapy for reduction of lipoprotein(a)

1 reference

12 December 2020

The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover

1 reference

12 December 2020

Dose-dependent inverse relationship between alcohol consumption and serum Lp(a) levels in black African males

1 reference

12 December 2020

Dynamics of plasma lipoproteins and lipids during double filtration plasmapheresis (DEP)

1 reference

12 December 2020

Identifiers

DOI

10.1194/JLR.P052209

1 reference

8 August 2017

1 reference

8 August 2017

1 reference